🔎 Trials Near Me

Beranda › PPOK › Maryland

Uji klinis PPOK di Maryland

16 studi untuk PPOK mencari peserta di lokasi di Maryland.

Kota di Maryland

Teks studi resmi (Bahasa Inggris)

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Johns Hopkins Bayview Medical Center- Site Number : 8400076, Baltimore
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07190222

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

  • Johns Hopkins Bayview Medical Center- Site Number : 8400009, Baltimore
Menerima pesertaFase 4
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07053423

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Baltimore
  • Research Site, Baltimore
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • Johns Hopkins University, Baltimore
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Baltimore
  • Research Site, Potomac
  • Research Site, Rosedale
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Baltimore
  • Research Site, Columbia
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06883305

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Oxon Hill
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06283966

STRIVE Post-Market Registry Study

  • University of Maryland, Baltimore
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT04302272

Multi-Center Clean Air Randomized Controlled Trial in COPD

  • University of Maryland, Baltimore
  • Johns Hopkins, Baltimore
  • Tidal Health, Salisbury
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06376994

SPIROMICS Study of Early COPD Progression (SOURCE)

  • Johns Hopkins Bayview Medical Center, Baltimore
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 hingga 55 · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05033990

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Rockville
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT06961214

Trial to Determine Effective Aspirin Dose in COPD

  • Johns Hopkins Bayview Medical Center, Baltimore
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 16 Mar 2026 · NCT05265299

OMEGA - Dietary Intervention - COPD Trial

  • Johns Hopkins Bayview Campus, Baltimore
Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 16 Mar 2026 · NCT05297279

Effectiveness of the WearME System for COPD Severity and Respiratory Function

  • Johns Hopkins, Baltimore
  • TidalHealth, Salisbury
Menerima pesertaStudi observasional
Usia 21 hingga 100 · Semua jenis kelamin · Diperbarui 9 Sep 2025 · NCT06751537

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • Ascension St. Agnes Hospital, Baltimore
Menerima pesertaStudi observasional
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  • University of Maryland - Baltimore, Baltimore
Menerima peserta
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 6 Feb 2025 · NCT05204888

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.